Versant Capital Management »

Janux Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $40k 2.6k 15.36
2026-03-31 $26k 1.8k 13.90

More positions owned by Versant Capital Management

Microsoft Stock (MSFT)
Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ishares S&p Global Energy Etf (IXC)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Avago Technologies Stock (AVGO)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Vanguard Total Stk Mkt Etf (VTI)

View all positions for Versant Capital Management

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Henderson Group
Prosight Management
FMR
State Street Corporation
Vanguard Capital Management
TCG Crossover Management
Alyeska Investment Group
Wellington Management Company
Vanguard Portfolio Management
Deep Track Capital
Point72 Asset Management
Geode Capital Management
Balyasny Asset Management

View all funds holding Janux Therapeutics